The website may be down at times on Saturday, December 14, and Sunday, December 15, for maintenance. 

  • Adult Immunization

    Study description

    We will implement a multicomponent approach consisting of clinical decision support, standing orders, improved documentation, and provider education, with the aim of increasing pneumococcal and influenza vaccination rates in at-risk adults aged 18+. At-risk is defined as all adults aged 65 and older and adults aged 19-64 who have certain risk factors. It is hypothesized that the intervention activities will lead to increased vaccination rates through improvements to the care delivery system at the study site.

    Methods

    A multi-component intervention targeting clinicians and consisting of clinical decision support, standing orders, audit and feedback, improved documentation, and focused clinician education. The intervention will be evaluated by analyzing data extracted from the study site EHR at regular intervals, as well as interviews with participating clinicians.

    Specific Aims

    1. Achieve at least a 20% improvement in immunization rates as compared to the baseline for pneumococcal and influenza immunizations in adult patients 65 years of age or older within the first 12 months following implementation of the intervention;
    2. Achieve at least a 20% improvement in immunization rates as compared to the baseline for pneumococcal and influenza immunizations in high-risk adult patients 19-64 years of age within the first 12 months following implementation of the intervention.

    Timeline

    March 1st, 2015 - October 31st, 2016

    Status

    This study is in the pre-intervention phase.

    Key findings and publications

    Missed opportunities for improving practice performance in adult immunizations: a meta-narrative review of the literature. Loskutova, N; Smail, C; Webster, B; Ajayi, K; Wood, J; Carroll, JK. (2017) BMC Family Practice 18:108; DOI 10.1186/s12875-017-0694-1.

    Contact Information

    Natalia Loskutova, MD PhD
    Director of Evaluation
    AAFP National Research Network
    (800) 274-2237, ext. 6149
    nloskutova@aafp.org

    Craig Smail, MA MSc 
    Research Project Manager
    AAFP National Research Network
    csmail@aafp.org

    This study is funded by an unrestricted grant from Merck